• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

戈谢病与帕金森病的分子关联理论。

Gaucher disease and parkinsonism, a molecular link theory.

机构信息

Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-3708, USA.

出版信息

Mol Genet Metab. 2010 Dec;101(4):307-10. doi: 10.1016/j.ymgme.2010.08.004. Epub 2010 Aug 10.

DOI:10.1016/j.ymgme.2010.08.004
PMID:20801700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2991511/
Abstract

Mutant GBA was found recently to be the most prevalent risk factor for familial parkinsonism. The two diseases do not share common symptoms and there is no direct pathway to explain the mechanism by which GBA mutations can confer the risk. Increased burden on the degradative pathway caused by defective glucocerebrosidase, or toxic side effects of glycosylated lipids accumulation were proposed to explain brain damage. Both hypotheses are not sufficient to explain the linkage. In order to develop a more inclusive theory we introduced into the model the prion theory and the second hit. Other possibilities are also brought into consideration.

摘要

最近发现,突变 GBA 是家族性帕金森病最常见的风险因素。这两种疾病没有共同的症状,也没有直接的途径可以解释 GBA 突变如何带来风险。有人提出,葡萄糖脑苷脂酶缺陷导致降解途径负担增加,或糖基化脂质积累的毒性副作用,可能导致大脑损伤。这两种假说都不足以解释这种关联。为了提出一个更具包容性的理论,我们将朊病毒理论和二次打击引入到模型中。同时也考虑了其他可能性。

相似文献

1
Gaucher disease and parkinsonism, a molecular link theory.戈谢病与帕金森病的分子关联理论。
Mol Genet Metab. 2010 Dec;101(4):307-10. doi: 10.1016/j.ymgme.2010.08.004. Epub 2010 Aug 10.
2
Parkinsonism among Gaucher disease carriers.戈谢病携带者中的帕金森综合征
J Med Genet. 2004 Dec;41(12):937-40. doi: 10.1136/jmg.2004.024455.
3
Exploring the link between glucocerebrosidase mutations and parkinsonism.探讨葡萄糖脑苷脂酶突变与帕金森病之间的联系。
Trends Mol Med. 2011 Sep;17(9):485-93. doi: 10.1016/j.molmed.2011.05.003. Epub 2011 Jul 1.
4
The association between ß-glucocerebrosidase mutations and parkinsonism.ß-葡糖脑苷脂酶突变与帕金森病的关联。
Curr Neurol Neurosci Rep. 2013 Aug;13(8):368. doi: 10.1007/s11910-013-0368-x.
5
Glucocerebrosidase mutations in subjects with parkinsonism.帕金森综合征患者中的葡萄糖脑苷脂酶突变
Mol Genet Metab. 2004 Jan;81(1):70-3. doi: 10.1016/j.ymgme.2003.11.004.
6
The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease.戈谢病与帕金森症之间的复杂关系:来自一种罕见疾病的见解
Neuron. 2017 Feb 22;93(4):737-746. doi: 10.1016/j.neuron.2017.01.018.
7
The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.与葡糖脑苷脂酶突变相关的帕金森氏症表现谱。
Arch Neurol. 2008 Oct;65(10):1353-7. doi: 10.1001/archneur.65.10.1353.
8
The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism.溶酶体蛋白葡萄糖脑苷脂酶突变与帕金森病的关联。
Mov Disord. 2009 Aug 15;24(11):1571-8. doi: 10.1002/mds.22538.
9
Gaucher-Associated Parkinsonism.戈谢病相关性帕金森综合征
Cell Mol Neurobiol. 2015 Aug;35(6):755-61. doi: 10.1007/s10571-015-0176-8. Epub 2015 Mar 29.
10
Parkinsonism, dementia and glucocerebrosidase mutations.帕金森综合征、痴呆与葡萄糖脑苷脂酶突变
J Neurol. 2013 May;260(5):1441-4. doi: 10.1007/s00415-013-6923-1.

引用本文的文献

1
Ideal animal models according to multifaceted mechanisms and peculiarities in neurological disorders: present and challenges.基于神经疾病多方面机制和特点的理想动物模型:现状与挑战
Arch Pharm Res. 2025 Jan;48(1):62-88. doi: 10.1007/s12272-024-01527-9. Epub 2024 Dec 18.
2
A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach.戈谢病综述:靶向β-葡萄糖脑苷脂酶的mRNA/saRNA疗法的治疗潜力
Int J Biol Sci. 2024 Mar 17;20(6):2111-2129. doi: 10.7150/ijbs.87741. eCollection 2024.
3
Animal models of Parkinson's disease: bridging the gap between disease hallmarks and research questions.帕金森病动物模型:弥合疾病特征与研究问题之间的差距。
Transl Neurodegener. 2023 Jul 19;12(1):36. doi: 10.1186/s40035-023-00368-8.
4
Fabry Disease With Concomitant Lewy Body Disease.伴有路易体病的法布里病。
J Neuropathol Exp Neurol. 2020 Apr 1;79(4):378-392. doi: 10.1093/jnen/nlz139.
5
The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.《拥挤的十字路口:帕金森病中线粒体、α-突触核蛋白与内溶酶体系统的相互作用》
Int J Mol Sci. 2019 Oct 25;20(21):5312. doi: 10.3390/ijms20215312.
6
Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice.多种致病蛋白与神经元型戈谢病小鼠有关。
Hum Mol Genet. 2014 Aug 1;23(15):3943-57. doi: 10.1093/hmg/ddu105. Epub 2014 Mar 5.
7
Loss of β-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells.β-葡糖脑苷脂酶活性丧失并不影响神经元细胞中α-突触核蛋白的水平或溶酶体功能。
PLoS One. 2013 Apr 8;8(4):e60674. doi: 10.1371/journal.pone.0060674. Print 2013.
8
A twelve-year follow-up study on a case of early-onset parkinsonism preceding clinical manifestation of Gaucher disease.关于一名在戈谢病临床表现之前出现早发性帕金森病病例的十二年随访研究。
JIMD Rep. 2012;3:53-7. doi: 10.1007/8904_2011_48. Epub 2011 Sep 20.
9
The link between the GBA gene and parkinsonism.GBA 基因与帕金森病之间的联系。
Lancet Neurol. 2012 Nov;11(11):986-98. doi: 10.1016/S1474-4422(12)70190-4.
10
Gaucher disease and the synucleinopathies: refining the relationship.戈谢病与突触核蛋白病:关系的再审视。
Orphanet J Rare Dis. 2012 Jan 31;7:12. doi: 10.1186/1750-1172-7-12.

本文引用的文献

1
The role of the lipid bilayer in tau aggregation.脂双层在 tau 聚集中的作用。
Biophys J. 2010 Jun 2;98(11):2722-30. doi: 10.1016/j.bpj.2010.03.013.
2
The propagation of prion-like protein inclusions in neurodegenerative diseases.朊病毒样蛋白在神经退行性疾病中的传播。
Trends Neurosci. 2010 Jul;33(7):317-25. doi: 10.1016/j.tins.2010.04.003. Epub 2010 May 20.
3
Prion-like disorders: blurring the divide between transmissibility and infectivity.朊病毒样疾病:传染性与感染性之间的界限日益模糊。
J Cell Sci. 2010 Apr 15;123(Pt 8):1191-201. doi: 10.1242/jcs.051672.
4
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.脑内 α-突触核蛋白在多系统萎缩、帕金森病和进行性核上性麻痹中的蓄积:一项比较性研究。
Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10.
5
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.帕金森病中葡萄糖脑苷脂酶突变的多中心分析。
N Engl J Med. 2009 Oct 22;361(17):1651-61. doi: 10.1056/NEJMoa0901281.
6
Immune cell types involved in early uptake and transport of recombinant mouse prion protein in Peyer's patches of calves.牛派尔集合淋巴结中早期摄取和转运重组鼠朊蛋白相关的免疫细胞类型。
Cell Tissue Res. 2009 Dec;338(3):343-54. doi: 10.1007/s00441-009-0879-6. Epub 2009 Oct 16.
7
Investigating bacterial sources of toxicity as an environmental contributor to dopaminergic neurodegeneration.研究毒性的细菌来源,将其视为导致多巴胺能神经退行性变的环境因素之一。
PLoS One. 2009 Oct 6;4(10):e7227. doi: 10.1371/journal.pone.0007227.
8
Is Parkinson's disease a prion disorder?帕金森病是一种朊病毒病吗?
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12571-2. doi: 10.1073/pnas.0906759106. Epub 2009 Jul 28.
9
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein.通过α-突触核蛋白在神经元间的传递形成包涵体并导致神经元细胞死亡。
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13010-5. doi: 10.1073/pnas.0903691106. Epub 2009 Jul 27.
10
Recommendations on the diagnosis and management of Niemann-Pick disease type C.尼曼-匹克病C型的诊断与管理建议。
Mol Genet Metab. 2009 Sep-Oct;98(1-2):152-65. doi: 10.1016/j.ymgme.2009.06.008. Epub 2009 Jun 14.